For the Quarter Ending September 2025
North America
• In the USA, the Magnesium Stearate Price Index rose by 7.8451% quarter-over-quarter, from inventory tightness.
• The average Magnesium Stearate price for the quarter was approximately USD 2424.00/MT, CFR Texas import basis.
• Magnesium Stearate Spot Price softened in June but rebounded by August as competitive export offers firmed.
• Magnesium Stearate Production Cost Trend turned upward following persistent stearic acid feedstock inflation, squeezing exporter margins.
• Magnesium Stearate Demand Outlook improved as pharmaceutical and nutraceutical restocking intensified, reducing available working inventories rapidly.
• Magnesium Stearate Price Forecast indicates near-term consolidation then modest firmness driven by seasonal procurement and inventory depletion.
• Elevated PMI readings supported the Magnesium Stearate Price Index momentum and increased buyer urgency during August.
Why did the price of Magnesium Stearate change in September 2025 in North America?
• Tightened inventories across downstream sectors drove urgent restocking, translating into stronger importer acceptance of higher export offers.
• Rising stearic acid feedstock costs increased production costs, pressuring exporter offers and elevating landed import prices.
• Smooth logistics prevented further spikes, but robust pharma and nutraceutical demand sustained price momentum in September.
APAC
• In China, the Magnesium Stearate Price Index rose by 6.49% quarter-over-quarter, driven by stearic costs.
• The average Magnesium Stearate price for the quarter was approximately USD 2270.00/MT, reflecting export mixes.
• Exporters constrained volumes which lifted the Magnesium Stearate Spot Price despite stable manufacturing and logistics.
• Near-term Magnesium Stearate Price Forecast suggests cautious upside as inventories normalize and buyers resume restocking.
• Rising stearic acid pushed Magnesium Stearate Production Cost Trend higher, pressuring margins and supplier offers.
• Magnesium Stearate Demand Outlook strengthened from pharmaceuticals and food sectors, prompting replenishment and forward buying.
• Magnesium Stearate Price Index volatility reflected export inquiry spikes, constrained inventories and port logistics efficiency.
• Major producers maintained steady operations, prioritizing contract customers while managing costs and selective export allocations.
Why did the price of Magnesium Stearate change in September 2025 in APAC?
• Higher stearic acid input costs raised production economics, prompting exporters to increase quotations despite stable logistics.
• Tightening pharmaceutical and food sector procurement reduced available export stocks, increasing buying urgency, supporting firmer prices.
• Elevated prior inventories moderated demand, but scheduled restocking and export inquiries pushed the Price Index upward.
Europe
• In Germany and major EU import hubs, the Magnesium Stearate Price Index rose by ~5.8% quarter-over-quarter, driven by higher stearic acid costs and tighter export availability.
• The average Magnesium Stearate price for the quarter was approximately USD 2,300/MT for CFR Rotterdam imports (conservative regional estimate).
• Magnesium Stearate Spot Price firmed as exporters constrained volumes and European formulators accelerated replenishment for pharmaceutical and food applications.
• Near-term Magnesium Stearate Price Forecast suggests cautious upside as inventories normalize and buyers resume routine restocking.
• Magnesium Stearate Production Cost Trend increased following stearic acid inflation, pressuring supplier margins and underpinning firmer offers.
• Magnesium Stearate Demand Outlook strengthened with pharmaceutical contract buying and seasonal food sector procurement supporting sustained offtake.
• Price Index movement reflected export inquiry spikes, selective allocation by suppliers, and efficient Rotterdam/Hamburg logistics that limited delivery delays.
• Major producers maintained steady operations, prioritizing contracted volumes while managing costs and selective export allocations to Europe.
Why did the price of Magnesium Stearate change in September 2025 in Europe?
• Rising stearic acid input costs raised production economics, prompting exporters to lift quotations.
• Constrained export volumes and active pharmaceutical/food sector replenishment reduced available spot stocks, tightening near-term availability and supporting higher prices.
• Efficient port and inland logistics prevented delivery bottlenecks, so the move was primarily demand- and cost-driven rather than logistics-led.
• Efficient Rotterdam/Hamburg port operations and steady inland logistics reduced premium volatility and supported orderly import flows.
• Stable plant run-rates at origins and manageable, but tightened, European stocks allowed consistent shipments, sustaining the Price Index momentum.
Why did the price of Magnesium Oxide change in September 2025 in Europe?
• Seasonal and programmatic feed dsssemand tightened available import volumes, increasing procurement urgency and lifting prices.
• Higher raw-material and energy costs raised production-cost support for exporters, contributing to firmer offers.
• Smooth port operations and steady export shipments meant price moves were driven mainly by demand/inventory dynamics rather than logistical disruption.
For the Quarter Ending June 2025
North America
• The Magnesium Stearate Spot Price averaged USD 2240/MT in June 2025 and reflected a mild Q2 price erosion of 0.67%. The price fluctuation was driven by subdued demand and elevated inventory levels across nutraceutical and personal care segments.
• The Magnesium Stearate Price Forecast was conservative throughout Q2 as importers prioritized inventory liquidation over new procurements amid stagnant end-user offtakes.
• In April 2025, the Price Index saw a sharp decline of 7.11% that was attributed to lower Chinese export offers. This price drop was a result of drop in the prices of Stearic Acid, and reduced US orders due to tariffs.
• May showed slight price stabilization (0.31% uptick) as pharma and food fortification sectors engaged in safety stock procurement and balanced import volumes without triggering speculative demand.
• By June, steady Magnesium Stearate Production Cost Trends in origin markets ensured consistent overseas supply, despite freight rate volatility and demand-side lethargy in US consumption.
• Importers entered Q2 with substantial inventory buffers, allowing for restrained buying strategies and limited spot transactions, keeping the Magnesium Stearate Spot Price within a tight range.
• No logistical disruptions were reported across Q2, with port and inland operations functioning efficiently, mitigating supply-side risk and preventing upward pressure on landed costs.
• Downstream sectors, particularly OTC and wellness-based nutraceuticals, showed no promotional drivers or seasonal push, muting the Magnesium Stearate Demand Outlook.
• Why did the price change in July 2025?
Exporters from key Asian hubs have adjusted their offers modestly to sustain market share but were unable to trigger any meaningful price rebound due to inventory overhang in the US.
Asia-Pacific
• The Magnesium Stearate Spot Price in June averaged USD 2120/MT, marking a marginal Q2 correction of 0.70% due to weak domestic and overseas downstream demand.
• The Magnesium Stearate Price Forecast remained flat-to-bearish across Q2, as both local and international buyers held off from forward orders amid routine offtake patterns.
• In April, falling Stearic Acid prices helped reduce the Magnesium Stearate Production Cost Trend, allowing suppliers to quote competitively despite stable output levels.
• May saw a minor 0.23% dip in the Price Index, shaped by cautious procurement and steady supply pipeline without any urgent restocking cues from foreign buyers.
• Exporters maintained regular shipment schedules with no port congestion or export curbs, ensuring that supply-side stability neutralized any upward pricing impulses.
• Elevated inventory levels by June, due to weak off-take in pharma and personal care segments, reinforced bearish sentiment in spot transactions.
• Despite stable production and feedstock pricing, the lack of seasonal demand surges or global promotional campaigns constrained the Magnesium Stearate Demand Outlook.
• Chinese suppliers avoided speculative pricing and focused on liquidity and inventory rotation, capping price movement within a narrow band throughout the quarter.
• Why did the price change in July 2025?
The demand from health supplement and OTC product formulators abroad remained routine in early July 2025 with no major global events triggering bulk orders.
Europe
• European Magnesium Stearate Spot Prices likely trended slightly downward in Q2 2025, in line with global market sentiment and steady import flow from Asia-based suppliers.
• The Magnesium Stearate Price Forecast for Q2 was shaped by stable production at origin markets and weak seasonal triggers across EU-based pharma and personal care manufacturers.
• April likely saw softening in the Price Index, influenced by lower Asian offers and easing freight rates, especially from Chinese ports to key European entry points.
• Mid-quarter, consistent production cost control and absence of raw material price shocks contributed to a steady Magnesium Stearate Production Cost Trend, which discouraged price hikes.
• European buyers likely mirrored U.S. and APAC procurement behaviour—working through Q1 stockpiles rather than initiating aggressive restocking, keeping demand neutral.
• No reports of supply chain disruptions or port delays suggest that import costs remained under control, helping stabilize regional landed prices.
• Pharmaceutical and cosmetic sector offtake in Europe remained largely contract-based and tied to routine demand, with no visible uptick in Magnesium Stearate Demand Outlook.
• Buyers remained price-sensitive throughout Q2, especially given the strong euro and moderate energy input cost levels across the continent.
• Why did the price change in July 2025?
Export quotations into Europe were stable-to-soft as global suppliers prioritized volume over margins in a tepid demand landscape in July 2025.
For the Quarter Ending March 2025
North America
In the first quarter of 2025 the prices of Magnesium Stearate in North America increased by an average of 11.68% compared to the previous quarter. The rise was mainly supported by improved demand from pharmaceutical and nutraceutical industries. Buyers showed strong interest as seasonal transition from winter to spring brought higher production activities across several sectors. Procurement remained active throughout the quarter.
Inventory levels were carefully managed by suppliers, which helped avoid sudden supply gaps. There were tariff changes during the quarter, but they did not have any significant impact on Magnesium Stearate prices. Supply conditions were smooth, and no major logistic bottlenecks were reported in North American region during first quarter of 2025.
Overall, higher usage in personal care and food-grade applications also supported the upward momentum. The positive sentiment in the domestic market coupled with anticipation of increased downstream production cycles contributed to price firmness. The combination of demand recovery and planned procurement made the first quarter fairly strong for Magnesium Stearate in the North American market.
Asia Pacific
Magnesium Stearate prices in Asia Pacific increased by an average of 7.87% from the previous quarter to the first quarter of 2025. This rise was a result of gradual improvement in demand across pharmaceutical and personal care industries. The increasing demand was supported by seasonal uptick in production activities and steady consumption patterns across end-user markets.
Strategic buying before the Chinese Lunar New Year contributed to the upward push in January. Post-holiday restocking by buyers in February and March kept consumption levels steady. Seasonal transition also played a part, as production in warmer months started picking up pace. Suppliers in key exporting regions maintained tight control over inventories, which limited supply availability at certain points during the quarter. Despite relatively stable costs of raw materials better export momentum helped support the overall price trend for the APAC region. Procurement remained smooth, and logistics faced no major challenges in the region. The general sentiment in the Asia Pacific market reflected healthy demand planning, and buyers remained focused on forward-looking needs. These combined factors led to a firm and gradual price increase for Magnesium Stearate throughout the first quarter of 2025.
Europe
In the first quarter of 2025, the price of Magnesium Stearate in Europe experienced a steady increase, aligning with global market trends. The pharmaceutical, nutraceutical and personal care sectors were key drivers of this rise, as demand in these industries remained strong. Strategic procurement practices and the effective management of inventory levels ensured a continuous supply, helping to avoid any significant supply disruptions.
Additionally, the seasonal transition played a role in maintaining stable demand. As the weather warmed, production activities across several downstream sectors, such as personal care and pharmaceuticals, saw an uptick, which further supported price stability. With an efficient logistics network in place, transportation remained smooth, and deliveries were timely, which contributed to the overall stability of the market.
The price increase can also be attributed to the growing confidence in procurement strategies and the healthy demand from downstream industries. Overall, the European Magnesium Stearate market displayed growth in the first quarter of 2025, in line with trends observed in other regions, indicating a balanced and well-supported market environment.
For the Quarter Ending December 2024
North America
During the entire fourth quarter of 2024, the U.S. Magnesium Stearate market exhibited an upward trend with a steady drop witnessed in the last two months influenced by a mix of supply chain disruptions, seasonal demand shifts, and global factors.
October saw a continued rise in import prices, driven by increased demand for excipients in food and pharmaceutical tablet formulations, combined with higher shipping costs from Asia. U.S. port challenges, particularly in New York, labor strikes, and delays exacerbated logistics issues, further raising costs. Strategic stockpiling and robust export activity, alongside rising feedstock costs for Stearic acid, also added to the price pressure. Additionally, global disruptions in Ukraine, the Middle East, and crude oil prices intensified these price hikes.
In November, import prices trended downward due to increased imports from China, driven by competitive production costs and a weaker yuan, which made Chinese exports more cost-effective. High domestic inventories, lower-than-expected demand from the pharmaceutical and food sectors, and improved logistics contributed to price pressures. However, market sentiment remained cautious as fluctuations in crude oil prices continued to influence production costs.
By December, the market showed a persistent decline in import prices, driven by weak demand from key downstream sectors, including preservatives. Elevated buyer inventories and subdued trading activity, along with increased competition from Chinese imports, contributed to a bearish market outlook for Magnesium Stearate.
Asia Pacific
During the entire fourth quarter of 2024, the Magnesium Stearate market in China experienced notable fluctuations, particularly in China across the Apac region. In October, prices surged due to severe supply constraints and strong demand. A typhoon disrupted shipping operations, causing delays and increasing freight costs, while downstream pharmaceutical and excipient sectors ramped up procurement ahead of seasonal production requirements. The market's pressure intensified due to a limited supply of feed stearic acid, further straining availability. Additionally, the depreciation of the Chinese yuan against the U.S. dollar raised import costs, benefiting traders through improved margins but limiting product availability. Major producers faced reduced stock levels, impacting both domestic and international markets.
By November, however, export prices began to decline as demand from key sectors like pharmaceuticals, personal care, and industrial applications slowed. Despite high feedstock costs, suppliers focused on competitive pricing to counteract diminished foreign orders, leading to aggressive destocking measures that exacerbated the oversupply situation. This oversupply combined with weak downstream absorption capacity drove prices down further. This trend continued until the final weeks of December marking an overall muted trading dynamic. This oversupply situation contributed to a pessimistic market outlook, highlighting the need for strategic actions like production cuts or demand stimulation efforts.
Europe
Germany saw an overall rise in Magnesium Stearate import prices during the fourth quarter of 2024, with a brief decline in November and December. In October, prices increased due to stronger seasonal demand from the food and pharmaceutical sectors, especially for excipient formulations, combined with rising shipping costs from key Asian suppliers. Logistics challenges, including delays at European ports and higher transportation expenses, further raised costs. Supply disruptions in key production regions, coupled with rising Stearic acid prices, added pressure. November saw some price stabilization as imports from China surged, driven by a weakened yuan and competitive production costs. However, demand remained weak, with slow off-takes in the food and pharmaceutical sectors, and high domestic inventories led to oversupply, which exerted downward pressure on prices. Improved logistics and lower freight costs also increased the availability of Magnesium Stearate from Asian suppliers. This trend continued even in December 2024, following persistent weak demand from downstream industries, keeping an overall market trading atmosphere on the southerly side.
